Lymphomes non hodgkiniens associés à l'infection par le VIH

Medecine Therapeutique

Volumn 2, Issue SUPPL. 1, 1996, Pages 72-84

  Oksenhendler, Éric ^a   Lévy, Yves ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE; VINDESINE;

BURKITT LYMPHOMA; CHEMOTHERAPY; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHODGKIN LYMPHOMA; REVIEW;

EID: 3142546370     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Gail M.H., et al. 1991. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst 83 : 695-701.
2. Amadori A., et al. 1991. B-cell activation during HIV-1 infection. II. Cell to cell interactions and cytokine requirement. J Immunol 145 : 57-62.
3. Birx D.L., Redfield R.R., Tencer K., Fowler A., Burke D.S., Tosato G. 1990. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76 : 2303-2310.
4. Chirmule N., et al. 1993. HIV-gp160-induced T cell-dependent B cell differentiation. J Immunol 150 : 2478-2486.
5. Nakajima K., et al. 1989. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta-2) production by human immunodeficiency virus. J Immunol 142 : 531-536.
6. Pluda J.M., et al. 1991. Factors which predict for the development of non-Hodgkin's lymphoma in patients with HIV infection receiving antiretroviral therapy. Blood 78 : 285a.
7. Émilie D., et al. 1992. Interleukin-6 production in high grade B lymphomas : correlation with the presence of malignant immunoblast in acquired immunodeficiency syndrome and in human immunodeficiency virus negative patients. Blood 80 : 498-508
8. Émilie D., et al. 1992. In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 22 : 2937-2942.
9. Benjamin D, Knobloch T.J., Dayton M.A. 1992. Human B-cell interleukin-10 : B cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80 . 1289-1298.
10. Burdin N., Peronne C., Banchereau J., Rousset F. 1993. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 177 : 295-304.
11. Fior R., et al. 1994. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Eur Cytokine Netw 5 : 593-600.
12. Yawerz S., Cumberland W.G , Van der Meyden M., Martinez-Maza O. 1995 Elevated serum levels of soluble CD23 (sCD23) precede the appearance of acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma Blood 85 : 1843-1849.
13. Klein G 1994. Epsfein-Barr virus strategy in normal and neoplastic B cells. Cell 177 : 791-793.
14. Hamilton-Dutoit S.J., et al. 1993. In situ demonstration of Epstein-Barr virus small RNAs (EBER-1) in acquired immunodeficiency syndrome-related lymphomas. Correlation with morphology and primary site. Blood 82 : 619-624.
15. Subar M., Neri A., Inghirami G., Knowles D.M., Dallo-Favera R. 1988. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72 : 667-671.
16. Shiramizu B., Herndier B., Meeker T., Kaplan L., MacGrath M. 1992. Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus negative, polyclonal lymphoma. J Clin Oncol 10 : 383-389.
17. Shibata D , Weiss L.M., Hernandez A.M., Nathwani B.N., Bernstein L., Levine M. 1993. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 81 : 2101-2109.
18. Ballerini P., et al. 1993. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81 : 166-176.
19. Delecluse H.J , et al. 1993. Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements. Blood 82 : 552-563.
20. Hamilton-Dutoit S.J., et al 1993. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Am J Pathol 143 : 1072-1085.
21. Gaidano G., et al. 1994. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma : association with diffuse large-cell subtype. Blood 84 : 397-402.
22. Raphael M., et al. 1994. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's iymphomas : correlation with histologic features in 36 cases. Am J Clin Pathol 101 : 773-782.
23. Carbone A., et al. 1995. AIDS-related Burkitt's lymphoma : morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 103 : 561-567.
24. Shibata D., Weiss L.M., Nathwani B.N., Brynes R.K., Levine A. 1991. Epstein-Barr virus in lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 77 : 1527-1533.
25. Neri A., et al. 1991. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency associated lymphoma. Blood 77 : 1092-1095.
26. Gulley M.L., Raphael M., Lutz C.T., Ross D.W., Raab-Traub N. 1992. Esptein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer 70 : 185-191.
27. Bhafia K., Spangler G., Gaidano G., Hamdy NL, Dalla-favera R., Magrath I. 1994. Mutations in the coding region of c-myc frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood 84 : 883-888.
28. Lombardi L., Newcomb E.W., Dalla-Favera R. 1987. Pathogenesis of Burkitt lymphoma : expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV infected human B lymphoblasts. Cell 49 : 161-170.
29. Cutrona G., Ulivi M., Fais F., Roncella S., Ferrarini M. 1995. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J Exp Med 181 : 699-711.
30. Adams J.M., et al. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318 : 533-538.
31. Pauza C.D., Galindo J., Richman D.D. 1988. Human immunodeficiency virus infection of monoblastoid cells : cellular differentiation determines the pattern of virus replication. J Virol 62 : 3558-3564.
32. Nakamura H., Said J W., Miller C.W., Koeffler H.P. 1993. Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas. Blood 82 : 920-926.
33. Pelicci P.G., et al. 1986. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders : implications for lymphomagenesis. J Exp Med 164 : 2049-2060.
34. Zelenetz A.D., Remache Y. 1993. HIV-associated immunoblastic lymphoma is derived from the germinal center and cional expansion is subsequent to antigenic selection. Blood 82 : 201a.
35. Riboldi P., et al. 1994. Two acquired immunodeficiency syndrome-associated Burkirt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments. Blood 83 : 2952-2961.
36. Ng V.L., et al. 1994. IgMs produced by two acquired immune deficiency syndrome lymphoma. Cell lines : Ig binding specificity and VH-gene putative somatic mutation analysis. Blood 83 : 1067-1078.
37. Ziegler J.L., et al. 1984. Non-Hodgkin's lymphoma in 90 homosexual men : relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311 : 565-570.
38. Levins A. 1992. Acquired immunodeficiency syndrome-related lymphoma. Blood 80 : 8-20.
39. Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles D.M. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332 : 1186-1191.
40. Raphaël M., Eclache V., Martin A., Feuillard J. 1995. Les lymphomes du Sida, médecine/sciences 11 : 713-722.
41. Thomas J.A., et al. 1993. Epstein-Barr virus-related oral T-cell lymphoma associated with human immunodeficiency virus immunosuppression. Blood 81 : 3350-3356.
42. Herndier B.G., Shiramizu B.T., Jewett N.E., Aldape K.D., Reyes G.R., McGrath M.S. 1992. Acquired immunodeficiency syndrome-associated T-cell lymphoma . evidence for human immunodeficiency virus type 1-associated T-cell transformation. Blood 79 : 1768-1774.
43. Ioachim H.L., Dorsett B., Cronin W., Maya M., Wahl S. 1991. Acquired immunodeficiency syndrome-associated lymphomas : clinical, pathologic, immunologic and viral characteristic of 111 cases. Hum Pathol 22 : 659-673.
44. Odajnyk C., et al. 1986. Clinical features and correlates with immunopathology and molecular biology of a large group of patients with AIDS associated small non-cleaved lymphoma (SNCL). Blood 68 : 131a.
45. Dugan M., et al. 1986. Intensive multiagent chemotherapy for AIDS-related diffuse large cell lymphoma. Blood 68 : 124a.
46. Gill P.S., et al 1987. AIDS-related malignant lymphoma : results of prospective treatment trials. J Clin Oncol 5 : 1322-1328.
47. Kaplan L.D., et al. 1989. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261 : 719-724.
48. Bermudez M., Grant K.M., Rodvien R., Mendes F. 1989. Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome : indications for intensive chemotherapy. Am J Med 86 : 71-76.
49. Levine A.M., et al. 1991. Low dose chemotherapy with central nervous system prophylaxis and azidothymidine maintenance in AIDS-related lymphoma : a prospective multi-institutional trial. JAMA 266 : 84-88.
50. Gisselbrecht C., et al. 1993. Human immunodeficiency virus-related lymphoma : treatment with intensive combination chemotherapy. Am J Med 95 : 188-196.
51. Kaplan L.D., et al. 1991. Clinical and virologie effects of recombtnant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma : results of a randomized trial. J Clin Oncol 9 : 929-940.
52. Walsh C., et al. 1993. Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. AIDS 6 : 265-271.
53. Kaplan L. 1995. ACTG 142 : the results of a randomized clinical trial of low-dose chemotherapy versus full chemotherapy and cytokine in AIDS lymphoma. In : 2nd National Conference on Human Retroviruses and Related Infections. Washington, January 29-February 2 1995.
54. th International Conference on AIDS. Yokohama, August 1994.
55. Soussain C., et al. 1995. Small non-cleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85 : 664-674.
56. Tirelli U., et al. 1992. Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related non-Hodgkin's lymphoma. Ann Oncol 3 : 843-847.
57. Sparano J.A., Wiernik P.H., Strack M., Leaf A., Becker N., Valentine S. 1993. Infusional cyclophosphamide, doxorubicin and etoposide in human immunodeficiency virus-and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma : a highly active regimen. Blood 81 : 2810-2815.
58. Émilie D., et al. 1994. Administration of an anti-interleukin-6 monoclinal antibody to patients with acquired immunodeficiency syndrome and lymphoma : effect on lymphoma growth and on B clinical symptoms. Blood 84 : 2472-2479.
59. Chamberlain M.C., Dirr L. 1993. Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis. J Clin Oncol 11 : 1978-1984.